Molecular requirements of chromogranin B for the long-sought anion shunter of regulated secretion
- PMID: 40107558
- PMCID: PMC12162349
- DOI: 10.1016/j.ijbiomac.2025.142180
Molecular requirements of chromogranin B for the long-sought anion shunter of regulated secretion
Abstract
All eukaryotes utilize regulated secretion to release molecular signals packaged in secretory granules for local and remote signaling. An anion shunt conductance was first suggested in secretory granules of bovine chromaffin cells nearly five decades ago. Biochemical identity of this conductance remains undefined. CLC-3, an intracellular Cl-/H+ exchanger, was proposed as a candidate sixteen years ago, which, however, was contested experimentally. Here, we show that chromogranin B (CHGB) makes the kernel of the long-sought anion shunter in cultured and primary neuroendocrine cells and its channel functions are essential to proper granule maturation. Intragranular pH measurements and cargo maturation assays revealed that normal granular acidification, proinsulin-insulin conversion, and dopamine-loading in neuroendocrine cells all rely on functional CHGB+ channels. Primary β-cells from Chgb-/- mice exhibited persistent granule deacidification, which suffices to uplift plasma proinsulin level, diminish glucose-induced 2nd-phase insulin secretion and dwindle monoamine content in chromaffin granules from the knockout mice. Data from targeted genetic manipulations, dominant negativity of a deletion mutant lacking channel-forming parts and tests of CLC-3/5 and ANO-1/2 all exclude CHGB-less channels from anion shunting in secretory granules. The highly conserved CHGB+ channels thus function in regulated secretory pathways in neuronal, endocrine, exocrine and stem cells of probably all vertebrates.
Keywords: Anion shunt pathway; Cargo maturation; Dopamine loading; Granule acidification; Hyperproinsulinemia; Neurodegenerative diseases; Neuroendocrine cancer; Proinsulin-to-insulin conversion; Regulated secretory pathways; Secretory granules; Type 2 diabetes (T2DM).
Copyright © 2025 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Update of
-
Molecular requirements of chromogranin B for the long-sought anion shunter of regulated secretion.bioRxiv [Preprint]. 2024 Dec 24:2024.12.24.630220. doi: 10.1101/2024.12.24.630220. bioRxiv. 2024. Update in: Int J Biol Macromol. 2025 May;309(Pt 1):142180. doi: 10.1016/j.ijbiomac.2025.142180. PMID: 39763853 Free PMC article. Updated. Preprint.
References
-
- Alberts B, Bray D, Hopkin K, Johnson A, Lewis J, Reff M, Roberts K, and Walter P (2011). Essential Cell Biology, Volume 1, 3rd Edition, (Garland Science, Part of Taylor & Francis Group, LLC; ).
-
- Dunzendorfer S, Feistritzer C, Enrich B, and Wiedermann CJ (2002). Neuropeptide-induced inhibition of IL-16 release from eosinophils. Neuroimmunomodulation 10, 217–223. - PubMed
-
- Paco S, Margeli MA, Olkkonen VM, Imai A, Blasi J, Fischer-Colbrie R, and Aguado F (2009). Regulation of exocytotic protein expression and Ca2+-dependent peptide secretion in astrocytes. J Neurochem 110, 143–156. - PubMed
-
- Shawe-Taylor M, Kumar JD, Holden W, Dodd S, Varga A, Giger O, Varro A, and Dockray GJ (2017). Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway. Peptides 91, 49–57. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
